Keros Therapeutics, Inc. (KROS) stock chart
KROSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3057% below fair value
$10.30+0.22 (+2.18%)
Close on Nov 13, 2026Market cap $204.22MP/E –Yield –
Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.
See a number that looks wrong?